FEYENALLY

Market position

Feyenally describes eyeTEST as the first and only solution providing objective refractive testing using only a smartphone, contrasting it with clinic-based examinations that rely on specialized equipment and subjective patient responses.

Differentiators stated by the company are objective, neural-network-based measurement rather than subjective patient response; operation on an unmodified smartphone without dedicated hardware; results delivered in seconds; patent protection in the U.S. and EU; and medical validation through independent studies.

Technology

The product uses neural network models applied to photographs of the eye captured with a standard smartphone camera and flash, guided by in-app AI instructions, to produce objective refractive error measurements (spherical, cylindrical, axis). The company cites U.S. patent protection (US 12,664,654) and states that its AI algorithms are patented in the United States and the European Union. It also states the technology has been validated in independent studies and that data handling is GDPR compliant.

Go-to-market

Feyenally distributes eyeTEST as a consumer-facing smartphone app and also works through partner organizations, supported by accelerator and competition visibility (Techstars, Health Tech Challengers, Santander X Global Challenge) and press coverage.

Individuals seeking basic eye testing and vision prescriptions outside of clinical settings, including those facing long wait times, travel requirements or limited access to eye care specialists; the company also references partner organizations.